bluebird bio is to ask regulators to restart clinical studies of its LentiGlobin for sickle cell disease, after an investigation concluded that a case of acute myeloid leukaemia (AML) was "very ...
More than 50% of parents say it takes 2 months or more to find childcare, leading to ‘unacceptable heights’ of stress 0 minutes ago 5 Tesla takeaways as shares ‘become completely divorced ...